Healthcare provider profile · identity verified

Christopher N Brunner, MD

Allopathic & Osteopathic Physicians|Family Medicine · WICHITA, KS · NPI 1851353254

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Christopher N Brunner, MD received $57.62 in general payments during 2025 across 3 reported records.

Medtronic, Inc. accounted for 39.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$57.62

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$22.56	39.1%	1	2025
Hologic Sales and Service, LLC	Unresolved — no canonical attribution shown	$19.19	33.3%	1	2025
Inspire Medical Systems, Inc.	Unresolved — no canonical attribution shown	$15.87	27.5%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$57.62	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
INTELLIS ADAPTIVESTIM Normalized: intellis adaptivestim	Device	Medtronic, Inc.	$22.56	1	2025
Source payment records 2025-03-13 · Medtronic, Inc. · $22.56 · Open Payments source
APTIMA Normalized: aptima	Device	Hologic Sales and Service, LLC	$19.19	1	2025
Source payment records 2025-01-28 · Hologic Sales and Service, LLC · $19.19 · Open Payments source
THINPREP 2000 PROCESSOR Normalized: thinprep 2000 processor	Device	Hologic Sales and Service, LLC	$19.19	1	2025
Source payment records 2025-01-28 · Hologic Sales and Service, LLC · $19.19 · Open Payments source
INSPIRE Normalized: inspire	Device	Inspire Medical Systems, Inc.	$15.87	1	2025
Source payment records 2025-10-28 · Inspire Medical Systems, Inc. · $15.87 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	650	152
Levothyroxine Sodium	Levothyroxine Sodium	545	112
Losartan Potassium	Losartan Potassium	436	104
Omeprazole	Omeprazole	435	90
Simvastatin	Simvastatin	406	102
Amlodipine Besylate	Amlodipine Besylate	383	98
Lisinopril	Lisinopril	308	75
Metformin Hcl	Metformin Hcl	282	67
Hydrochlorothiazide	Hydrochlorothiazide	236	57
Pantoprazole Sodium	Pantoprazole Sodium	224	52
Glimepiride	Glimepiride	208	49
Rosuvastatin Calcium	Rosuvastatin Calcium	200	51
Tamsulosin Hcl	Tamsulosin Hcl	192	46
Zolpidem Tartrate	Zolpidem Tartrate	179	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	174	49
Sertraline Hcl	Sertraline Hcl	166	37
Metoprolol Succinate	Metoprolol Succinate	162	38
Ozempic	Semaglutide	154	20
Potassium Chloride	Potassium Chloride	154	35
Alprazolam	Alprazolam	148	37
Gabapentin	Gabapentin	148	32
Diclofenac Sodium	Diclofenac Sodium	144	37
Citalopram Hbr	Citalopram Hydrobromide	111	25
Tramadol Hcl	Tramadol Hcl	111	27
Alendronate Sodium	Alendronate Sodium	107	25
Meloxicam	Meloxicam	99	27
Ezetimibe	Ezetimibe	97	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	97	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	95	18
Allopurinol	Allopurinol	91	18
Escitalopram Oxalate	Escitalopram Oxalate	90	21
Jardiance	Empagliflozin	88	17
Trazodone Hcl	Trazodone Hcl	86	16
Furosemide	Furosemide	82	19
Albuterol Sulfate Hfa	Albuterol Sulfate	79	24
Cefdinir	Cefdinir	77	63
Lovastatin	Lovastatin	72	19
Januvia	Sitagliptin Phosphate	71	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	71	19
Eliquis	Apixaban	70	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	69	12
Methylprednisolone	Methylprednisolone	63	52
Atenolol	Atenolol	62	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	15
Tizanidine Hcl	Tizanidine Hcl	60	28
Warfarin Sodium	Warfarin Sodium	60	15
Fluoxetine Hcl	Fluoxetine Hcl	59	12
Glipizide Er	Glipizide	59	12
Clopidogrel	Clopidogrel Bisulfate	57	16
Doxycycline Hyclate	Doxycycline Hyclate	54	47
Estradiol	Estradiol	54	18
Prednisone	Prednisone	52	28
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	40
Finasteride	Finasteride	49	suppressed
Tresiba Flextouch U-100	Insulin Degludec	49	suppressed
Duloxetine Hcl	Duloxetine Hcl	48	suppressed
Fenofibrate	Fenofibrate	48	suppressed
Baclofen	Baclofen	47	suppressed
Ondansetron Odt	Ondansetron	47	24
Levofloxacin	Levofloxacin	46	35
Fluticasone Propionate	Fluticasone Propionate	44	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Montelukast Sodium	Montelukast Sodium	40	13
Paroxetine Hcl	Paroxetine Hcl	40	11
Synthroid	Levothyroxine Sodium	40	suppressed
Bupropion Xl	Bupropion Hcl	39	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Valsartan	Valsartan	38	suppressed
Celecoxib	Celecoxib	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	12
Tolterodine Tartrate Er	Tolterodine Tartrate	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Ibandronate Sodium	Ibandronate Sodium	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	14
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Lorazepam	Lorazepam	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Ibuprofen	Ibuprofen	30	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	28	suppressed
Bumetanide	Bumetanide	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Etodolac	Etodolac	28	suppressed
Fluconazole	Fluconazole	28	13
Carvedilol	Carvedilol	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	27	27
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	26
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Cefprozil	Cefprozil	26	20
Mounjaro	Tirzepatide	26	suppressed
Pregabalin	Pregabalin	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	18
Eszopiclone	Eszopiclone	24	suppressed
Glipizide	Glipizide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Ketoconazole	Ketoconazole	23	14
Buspirone Hcl	Buspirone Hcl	22	suppressed
Fenofibrate	Fenofibrate,micronized	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Torsemide	Torsemide	22	suppressed
Amoxicillin	Amoxicillin	21	15
Benazepril Hcl	Benazepril Hcl	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Famotidine	Famotidine	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Cephalexin	Cephalexin	17	17
Clonidine Hcl	Clonidine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Risperidone	Risperidone	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Primidone	Primidone	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	11
Dutasteride	Dutasteride	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Naproxen	Naproxen	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Livalo	Pitavastatin Calcium	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$57.62 · 3 records	Medtronic, Inc.	APTIMA, INSPIRE, INTELLIS ADAPTIVESTIM, THINPREP 2000 PROCESSOR	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error